Halofuginone

From Self-sufficiency
Jump to: navigation, search
Halofuginone
File:Halofuginone.png
Systematic (IUPAC) name
7-Bromo-6-chloro-3-[3-[(2S,3R)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-4-quinazolinone
Identifiers
CAS Number 55837-20-2
ATCvet code QP51AX08 (WHO)
PubChem CID 62891
Chemical data
Formula C16H17BrClN3O3
Molar mass 414.68 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Halofuginone is a coccidiostat used in veterinary medicine. It is a synthetic halogenated derivative of febrifugine, a natural quinazolinone alkaloid which can be found in the Chinese herb Dichroa febrifuga (Chang Shan).[1] Collgard Biopharmaceuticals is developing halofuginone for the treatment of scleroderma and it has received orphan drug designation from the U.S. Food and Drug Administration.[2]

Halofuginone inhibits the development of T helper 17 cells, immune cells that play an important players in autoimmune disease, but it does not affect other kinds of T cells which involved in normal immune function.[3] Halofuginone therefore has potential for the treatment of autoimmune disorders.[4]

Halofuginine is also an inhibitor of collagen type I gene expression and as a consequence it may inhibit tumor cell growth.[1]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />
  1. 1.0 1.1 Halofuginone hydrobromide, NCI Drug Dictionary
  2. Halofuginone Receives FDA Orphan Drug Status For Scleroderma, March 10, 2000
  3. Sundrud, M. S.; Koralov, S. B.; Feuerer, M.; Calado, D. P.; Kozhaya, A. E.; Rhule-Smith, A.; Lefebvre, R. E.; Unutmaz, D.; Mazitschek, R. (2009). "Halofuginone Inhibits TH17 Cell Differentiation by Activating the Amino Acid Starvation Response". Science. 324 (5932): 1334. doi:10.1126/science.1172638. PMC 2803727Freely accessible. PMID 19498172. 
  4. A new lead for autoimmune disease: A small-molecule drug inhibits Th17 cells, eases symptoms in mouse model, June 4, 2009